Becton, Dickinson and Co. | BDX - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Abbott USD 1.74B 2.94M 2026-03
Agilent USD 281.97M 252K 2026-06
Align Technology USD 71.62M 1000 2026-06
AngioDynamics USD 41.57M 127K 2025-09
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 190.1M 5.01M 2026-06
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Globus Medical USD 135.67M 611K 2026-03
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 130K 2026-06
Solventum Corp USD 170.11M 3.42M 2026-06
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
Terumo JPY 1.48B 19K 2026-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06